Qube Research & Technologies »

Lyra Therapeutics shares owned by Qube Research & Technologies

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Qube Research & Technologies from 13F filings

Historical chart of Qube Research & Technologies investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Qube Research & Technologies

Quarter filed Position value Share count Share price at filing
2023-09-30 $13k 3.3k 3.91

More positions owned by Qube Research & Technologies

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Amazon Call Option (AMZN)
Visa Com Cl A Call Option (V)
Meta Platforms Cl A Call Option (META)
Adobe Systems Incorporated Call Option (ADBE)
McDonald's Corporation Call Option (MCD)
NVIDIA Corporation Call Option (NVDA)
salesforce Call Option (CRM)
Netflix Call Option (NFLX)
Johnson & Johnson Put Option (JNJ)
Cisco Systems Put Option (CSCO)
Bank of America Corporation Call Option (BAC)

View all positions for Qube Research & Technologies

Top funds holding Lyra Therapeutics

Perceptive Advisors
Nantahala Capital Management
Point72 Asset Management
Citadel Advisors
Samsara BioCapital
VR Adviser
Ikarian Capital
Rosalind Advisors
Vanguard Group
Millennium Management
Alyeska Investment Group
Bank of America Corporation
Two Sigma Investments
Citigroup
Clearline Capital

View all funds holding Lyra Therapeutics